Press Releases
Hyperion Therapeutics to Present at BIO CEO Investor Conference
South San Francisco, CA - February 7, 2008Hyperion Therapeutics, Inc. today announced that the company is scheduled to present at the BIO CEO and Investor Conference on Monday February 11 at 1:15pm Eastern Time at The Waldorf-Astoria Hotel in New York City. Chris Rivera, President and Chief Executive Officer, will provide an overview of the company’s commercial division and clinical development programs.
About Hyperion Therapeutics
Hyperion Therapeutics is a fully-integrated specialty therapeutics company committed to becoming a global leader in the development and commercialization of hepatology and gastrointestinal therapies that address orphan or underserved patient populations with unmet medical needs. Hyperion’s commercial operations division currently markets two products in the United States for urea cycle disorder. Hyperion is headquartered in South San Francisco, CA. For additional information, visit: www.hyperiontx.com.
Press Contact
Chris Rivera
President and CEO
Hyperion Therapeutics, Inc.
650-745-7802